Copyright
©2011 Baishideng Publishing Group Co.
World J Diabetes. Nov 15, 2011; 2(11): 176-188
Published online Nov 15, 2011. doi: 10.4239/wjd.v2.i11.176
Published online Nov 15, 2011. doi: 10.4239/wjd.v2.i11.176
Figure 6 Scheme showing the role of eicosanoids, lipoxins, resolvins, protectins and maresins in resolution of non-alcoholic fatty liver disease.
Green arrows indicate events that will lead to resolution of non-alcoholic fatty liver disease (NAFLD). Red arrows indicate events that will lead to initiation and/or progression of NAFLD. (-): Inhibition or suppression of action; (+): Activation or enhancement of action; TNF-α: Tumor necrosis factor-α; LXs: Lipoxins; COX: Cyclo-oxygenase; LO: Lipoxygenase; PG: Pro-inflammatory prostaglandin. For further details see[82-90,119].
- Citation: Das UN. A defect in the activities of Δ6 and Δ5 desaturases and pro-resolution bioactive lipids in the pathobiology of non-alcoholic fatty liver disease. World J Diabetes 2011; 2(11): 176-188
- URL: https://www.wjgnet.com/1948-9358/full/v2/i11/176.htm
- DOI: https://dx.doi.org/10.4239/wjd.v2.i11.176